Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dr Reddys Laboratories ADR repsg 1 Ord Shs RDY

Healthcare
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The... see more

Recent & Breaking News (NYSE:RDY)

Scott+Scott, Attorneys at Law, LLP Announces Filing of Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY)

PR Newswire August 29, 2017

INVESTOR ALERT: Goldberg Law Pc Announces the Filing of a Securities Class Action Lawsuit against Vitamin Shoppe, Inc.

Business Wire August 28, 2017

DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm

GlobeNewswire August 28, 2017

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Dr. Reddy’s Laboratories Limited Investors

Business Wire August 28, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Dr. Reddy’s Laboratories Limited

Business Wire August 28, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dr. Reddy's Laboratories Ltd. (RDY) & Lead Plaintiff Deadline: October 24, 2017

PR Newswire August 28, 2017

Dr. Reddy’s Laboratories Breathes New Life into Doan’s® in New Marketing Campaign

Business Wire August 28, 2017

Dr. Reddy's Laboratories Announces the Launch of Cefixime for Oral Suspension, USP in the U.S. Market

Business Wire August 28, 2017

DR. REDDY’S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd. – (RDY)

GlobeNewswire August 26, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm

Business Wire August 25, 2017

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Dr. Reddy’s Laboratories Ltd.

Business Wire August 25, 2017

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors

Business Wire August 23, 2017

25 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  August 22, 2017

Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology

Business Wire August 22, 2017

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Dr. Reddy’s Laboratories Limited

Business Wire August 14, 2017

Dr. Reddy's (RDY) Alert: J&W Investigates Dr. Reddy's Laboratories Ltd.; Has Your Dr. Reddy's Investment Declined in Value?

PR Newswire August 12, 2017

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Dr. Reddy’s Laboratories Limited and Encourages Investors with Losses to Contact the Firm

Business Wire August 11, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Dr. Reddy’s Laboratories, Ltd. Investors

Business Wire August 11, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Dr. Reddy’s Laboratories Limited

Business Wire August 11, 2017

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  August 11, 2017